首页> 外国专利> ApxIVA Composition for diagnosing infection of Actinobacillus pleuropneumoniae containing recombinant antigen protein of ApxIVA

ApxIVA Composition for diagnosing infection of Actinobacillus pleuropneumoniae containing recombinant antigen protein of ApxIVA

机译:用于诊断含有ApxIVA重组抗原蛋白的胸膜肺炎放线杆菌的感染的ApxIVA组合物

摘要

The present invention relates to a composition for diagnosing Actinobacillus pleuropneumoniae (App) infection, comprising a recombinant antigen protein of exotoxin ApxIVA of App; a kit for diagnosing App infection, comprising the composition; and a method for diagnosing App infection in a non-human subject by using the kit. The present invention has discovered an antigen candidate region capable of diagnosing a subject naturally infected with App by using the exotoxin ApxIVA. In particular, the ApxIVA recombinant antigen protein of the present invention selected by structural estimation of exotoxin ApxIV proteins can diagnose App infection with high specificity and sensitivity without causing cross-reactions between Apx exotoxins.
机译:本发明涉及用于诊断胸膜肺炎放线杆菌(App)的感染的组合物,其包含App的外毒素ApxIVA的重组抗原蛋白。用于诊断App感染的试剂盒,其包含所述组合物;以及使用该试剂盒诊断非人类受试者的App感染的方法。本发明已经发现了能够通过使用外毒素ApxIVA来诊断自然地被App感染的受试者的抗原候选区域。特别地,通过外毒素ApxIV蛋白的结构估计选择的本发明的ApxIVA重组抗原蛋白可以高特异性和高灵敏度地诊断App感染,而不会引起Apx外毒素之间的交叉反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号